Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.
about
Bioactive peptides from muscle sources: meat and fishNatural Products to Counteract the Epidemic of Cardiovascular and Metabolic DisordersMarine-Based Nutraceuticals: An Innovative Trend in the Food and Supplement IndustriesJeju seaweeds suppress lipopolysaccharide-stimulated proinflammatory response in RAW 264.7 murine macrophages.STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.Potential anti-HIV agents from marine resources: an overview.Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseasesBioactive peptides and depsipeptides with anticancer potential: sources from marine animalsBioactive Peptide of Marine Origin for the Prevention and Treatment of Non-Communicable DiseasesIsolation and structural determination of two novel phlorotannins from the brown alga Ecklonia kurome Okamura, and their radical scavenging activities.Separation and Characterization of Angiotensin I Converting Enzyme (ACE) Inhibitory Peptides from Saurida elongata Proteins Hydrolysate by IMAC-Ni2.Antihypertensive peptides from food proteins: a review.Review on the angiotensin-I-converting enzyme (ACE) inhibitor peptides from marine proteins.Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisRecent Research in Antihypertensive Activity of Food Protein-derived Hydrolyzates and Peptides.Hard clam extracts induce atypical apoptosis in human gastric cancer cells.Antitumor activity of a sulfated polysaccharide from Enteromorpha intestinalis targeted against hepatoma through mitochondrial pathway.Antitumor activity of a polysaccharide fraction from Laminaria japonica on U14 cervical carcinoma-bearing mice.Wild Mushrooms in Nepal: Some Potential Candidates as Antioxidant and ACE-Inhibition Sources.Lobster processing by-products as valuable bioresource of marine functional ingredients, nutraceuticals, and pharmaceuticals.In vitro, ex vivo and in vivo anti-hypertensive activity of Chrysophyllum cainito L. extract.Optimization of Bromelain-Aided Production of Angiotensin I-Converting Enzyme Inhibitory Hydrolysates from Stone Fish Using Response Surface Methodology.Optimization of hydrolysis conditions for the production of angiotensin-I converting enzyme-inhibitory peptides and isolation of a novel peptide from lizard fish (Saurida elongata) muscle protein hydrolysate.Angiotensin I-Converting Enzyme (ACE) Inhibitory Activity, Antioxidant Properties, Phenolic Content and Amino Acid Profiles of Fucus spiralis L. Protein Hydrolysate Fractions.Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats.Recent advances in pharmacological research on Ecklonia species: a review.Nutritional and Functional Bioactivity Value of Selected Azorean Macroalgae: Ulva compressa, Ulva rigida, Gelidium microdon, and Pterocladiella capillacea.Imminent Angiotensin-converting Enzyme Inhibitor from Microbial Source for Cancer Therapy.Bioactive Peptides Derived from Seaweed Protein and Their Health Benefits: Antihypertensive, Antioxidant, and Antidiabetic Properties.Vicilin-A major storage protein of mungbean exhibits antioxidative potential, antiproliferative effects and ACE inhibitory activity.Chemical evaluation of the Rhynchophorus ferrugineus larvae fed on different substrates as human food source.Quantification of phenolics in Syzygium cumini seed and their modulatory role on tertiary butyl-hydrogen peroxide-induced oxidative stress in H9c2 cell lines and key enzymes in cardioprotection.Production and characterization of functional properties of protein hydrolysates from egg shell membranes by lactic acid bacteria fermentation.Bioactive and functional properties of protein hydrolysates from fish frame processing waste using plant proteases.Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE) - inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design.Potential Role of Seaweed Polyphenols in Cardiovascular-Associated DisordersOverview on the Antihypertensive and Anti-Obesity Effects of Secondary Metabolites from SeaweedsRed and green macroalgae for fish and animal feed and human functional food developmentIn VitroAntibacterial Activity and Synergistic Antibiotic Effects of Phlorotannins Isolated fromEisenia bicyclisAgainst Methicillin-ResistantStaphylococcus aureus
P2860
Q24610066-093D226E-7DDA-4EC7-93DF-3EA18E11C051Q26747523-248D97F4-DE5B-420B-83AE-613305DCAC0BQ26782434-932996D0-6D01-40A2-B95F-02CE34E912C9Q33657540-65F5B4B1-AB55-4051-88A5-7C62F41B367CQ33732962-AF171236-D619-4716-9EFB-C647AC2E3B22Q33963521-D107D7E2-E27F-4C03-9E3A-4A31B30B2BC9Q34576118-359484AB-BC99-45E0-BD86-4A97B03A056CQ35091730-D397C7D4-FDFB-4A40-B429-9123C48DF86FQ36096750-982DD28F-205B-4976-B3FE-822C2CEED072Q36304654-BCDC80A1-E6DA-470B-A3C8-84C77E782F60Q36587008-196F3493-D1DC-474D-9B6B-1F91EDCF1582Q37678284-EF11670D-36D2-4C27-8B44-8D934C7D73E1Q37976373-71B99850-8712-46F8-AFE0-0FFD2C67C804Q38070125-2E5D7833-5CC7-48DE-B738-93C6294D1BDEQ38123670-43FE8F78-A04C-4C83-8A05-97C546C996E8Q38230938-1023044D-D218-4768-9528-05903CBA3DC0Q38642150-20F4EF94-3D76-4BEF-958D-6F3C2C70B9D6Q39066455-41727DBA-3B22-4D86-A32A-7A77F33833F4Q39114236-95DAF3EC-CF9F-4B8C-B587-3E1EE6054A02Q39221864-AA5E2E50-DCC8-4CBA-AE8F-1E4E86DD9EE9Q39416830-EAF7D7C3-DE90-43E7-B274-D2091E255944Q41574401-C097D0FC-6DA0-4DCF-96AA-BE316529A21AQ42045640-E074624D-738B-42D6-83FF-CC2C694A3971Q42237822-43BEFF20-672A-49A3-B883-8730C2ADB225Q44696924-2DC026BE-E3BB-4DAE-88F8-EE26288EF9DBQ44796513-50B4B218-CC3D-4B56-914A-5DBD47ACD942Q46316469-364DDBB5-8FF2-4785-8538-3543EE17BA7AQ46349125-D9DF7CD6-7606-4F4F-A251-5B0D0E54A9E3Q47139933-15A4892D-BB4B-4405-B701-7F64209A884EQ47262178-01B2E605-9C93-48DD-B8B5-38845E2736F9Q48097727-0B21FE8B-3C64-4F68-8C19-27D553DC82C9Q50209977-B6559192-BCB4-431E-8D54-5EBE65AF6540Q50883174-E74D72CD-0BB3-449C-9B86-B04AD29DCF89Q50912990-40E428CA-2068-4204-9941-128299C808C9Q51469453-0D539C58-19AC-40C3-816A-9488F6BF86D1Q55668817-79D5C263-17C3-4346-BE8F-B066A626A1CBQ57174315-930767F9-1D6B-4108-A336-043756C442D4Q57176064-749783E4-F5B8-44F6-BF22-D9D46200C82AQ57255546-4BEBA1AD-C9FA-4CB3-B7C9-506854C0FD11Q57846985-70BCCE0E-9313-4F56-845A-DC4CB59DAB56
P2860
Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiotensin-I-converting enzym ...... n the pharmaceutical industry.
@ast
Angiotensin-I-converting enzym ...... n the pharmaceutical industry.
@en
type
label
Angiotensin-I-converting enzym ...... n the pharmaceutical industry.
@ast
Angiotensin-I-converting enzym ...... n the pharmaceutical industry.
@en
prefLabel
Angiotensin-I-converting enzym ...... n the pharmaceutical industry.
@ast
Angiotensin-I-converting enzym ...... n the pharmaceutical industry.
@en
P2860
P356
P1433
P1476
Angiotensin-I-converting enzym ...... n the pharmaceutical industry.
@en
P2093
Isuru Wijesekara
Se-Kwon Kim
P2860
P304
P356
10.3390/MD8041080
P577
2010-03-31T00:00:00Z